Anti-Sox2 antibody conjugated liposomes hold significant potential in research, particularly for targeting subcutaneous F9 teratocarcinoma tumors. By specifically binding to Sox2, a stem cell marker associated with tumor progression and maintenance, these liposomes can enhance the precision of therapeutic interventions. This targeted approach may improve the efficacy of drug delivery while minimizing off-target effects, thereby reducing systemic toxicity. Furthermore, studying the interactions and efficacy of these conjugated liposomes could provide insights into stem cell characteristics in tumors and contribute to the development of more effective cancer therapies.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-3377 | Hi-Affi™ Recombinant Rabbit Anti-SOX2 Monoclonal Antibody (DS3377AB) | ICC, IHC-P, WB, sELISA | IgG |
MOR-0107-FY | Rabbit Anti-SOX2 Recombinant Antibody (clone AFY0078) | ICC, IHC-P, WB | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY243. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.